Newsroom | 17677 results
Sorted by: Latest
-
Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March 11, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (646) 564-2877 for U.S. participants, o...
-
Addus HomeCare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather...
-
Aledade Adds a Record 700 New Primary Care Organizations to its Value-Based Care Network for 2026
BETHESDA, Md.--(BUSINESS WIRE)--Aledade today announced that it has added more than 700 primary care organizations to its value-based care network for the 2026 performance year....
-
Boothwyn Pharmacy Earns Prestigious National Pharmacy Accreditation
KENNETT SQUARE, Pa.--(BUSINESS WIRE)--Boothwyn Pharmacy, a national compounding pharmacy serving humans and animals, earned full accreditation under one of the industry’s most rigorous and respected pharmacy oversight programs – the National Association of Boards of Pharmacy’s (NABP) Verified Pharmacy Program. The inspection involved an extensive, multi-day evaluation of Boothwyn Pharmacy’s operations, facilities, and quality systems. Surveyors reviewed policies, procedures, equipment, and reco...
-
Accanto Health Expands Executive Leadership Team
ST. PAUL, Minn.--(BUSINESS WIRE)--Jay Campbell joins Accanto Health and The Emily Program as President....
-
athenahealth and b.well Introduce Patient-Controlled Digital Health Data Sharing at the Point of Care
BOSTON & BALTIMORE--(BUSINESS WIRE)--athenahealth and b.well Connected Health today announced a new point-of-care workflow allowing patients to securely share their health information digitally during intake—without paper forms, faxes, or multiple portal logins. The companies expect a broader rollout of this capability in 2026. The new workflow advances the Centers for Medicare & Medicaid Services’ (CMS) Health Tech Ecosystem Initiative goal to replace manual intake and fragmented data exch...
-
The Global Mobile Medical Association Launches to Transform Community Healthcare with Unified Network
GREENSBORO, N.C.--(BUSINESS WIRE)--The Global Mobile Medical Association (GMMA), the world’s first comprehensive network dedicated to advancing the mobile healthcare model, officially launched today. GMMA represents a turning point for mobile medicine, uniting community health professionals, mobile health program operators, telemedicine champions, mobile integrated health professionals, and healthcare technology innovators under a shared mission: ensuring efficient access to and cost-effective...
-
Best Upon Request Announces Ownership Transition and New CEO
CINCINNATI--(BUSINESS WIRE)--Best Upon Request announces an ownership transition, with Cory McCruden becoming owner and CEO following Tillie Hidalgo Lima’s retirement....
-
Safanad Announces the Sale of HC-One, the UK’s Largest Care Home Provider, to a Leading Healthcare REIT
NEW YORK & RIYADH, Saudi Arabia--(BUSINESS WIRE)--Safanad, a principal-led investment company that builds world-class businesses, is pleased to announce the successful sale of HC-One, the UK’s largest care home provider, with nearly 300 homes and servicing around 15,000 residents, to a leading healthcare real estate investment trust (REIT), at a sale price over US$ 1.6 billion. The sale concludes a ten-year investment and business-building period during which Safanad led HC-One’s transformation...
-
EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities
BOSTON--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, in collaboration with President Trump’s administration, announced new patient access pathways to make its complete portfolio of infertility medications used for in vitro fertilization (IVF), including Gonal-f® (follitropin alfa for injection), Ovidrel® (choriogonadotropin alfa injection), and Cetrotide® (cetrorelix acetate for injection), more accessible to prescribed infertili...